EPRS1-mediated fibroblast activation and mitochondrial dysfunction promote kidney fibrosis
Authors:
Preprint
- 6 June 2024
- preprint
- Published by Springer Nature in Research Square
Abstract
Kidney fibrosis is characterized by an aberrant extracellular matrix accumulation. Glutamyl-prolyl-tRNA synthetase 1 (EPRS1) is a crucial enzyme involved in the synthesis of proline-rich proteins. However, its role in kidney fibrosis remains unclear. The present study found that EPRS1 expression levels were increased in the fibrotic kidneys of patients and mice. We also found that fibroblasts and proximal tubular epithelial cells were major sources of EPRS1 based on single-cell analysis and immunostaining of fibrotic kidneys. C57BL/6 EPRS1tm1b heterozygous knockout (Eprs1+/−) attenuated kidney fibrosis and dysfunction by preventing fibroblast activation and proximal tubular injury. In vitro assays demonstrated that EPRS1-induced Smad3 phosphorylation promotes fibroblast activation, proliferation, and resultant collagen production under transforming growth factor-β treated conditions. We also found that EPRS1 could lead to STAT3 phosphorylation to induce mitochondrial dysfunction in injured proximal tubules. Moreover, first-in-class EPRS1 inhibitor DWN12088 effectively protected against kidney fibrosis and dysfunction. Our findings suggest that EPRS1-mediated extracellular matrix induces kidney fibrosis via fibroblast activation and mitochondrial dysfunction.Keywords
All Related Versions
This publication has 42 references indexed in Scilit:
- Kidney Decellularized Extracellular Matrix Enhanced the Vascularization and Maturation of Human Kidney OrganoidsAdvanced Science, 2022
- In vivo silencing of amphiregulin by a novel effective Self-Assembled-Micelle inhibitory RNA ameliorates renal fibrosis via inhibition of EGFR signalsScientific Reports, 2021
- Characterization of Matricellular Protein Expression Signatures in Mechanistically Diverse Mouse Models of Kidney InjuryScientific Reports, 2019
- Aminoacyl-tRNA synthetases as therapeutic targetsNature Reviews Drug Discovery, 2019
- Infection-specific phosphorylation of glutamyl-prolyl tRNA synthetase induces antiviral immunityNature Immunology, 2016
- Mitochondrial Fission and Fusion Factors Reciprocally Orchestrate Mitophagic Culling in Mouse Hearts and Cultured FibroblastsCell Metabolism, 2015
- Understanding the origin, activation and regulation of matrix‐producing myofibroblasts for treatment of fibrotic diseaseThe Journal of Pathology, 2013
- Models of chronic kidney diseaseDrug Discovery Today: Disease Models, 2010
- Renal fibrosis: New insights into the pathogenesis and therapeuticsKidney International, 2006
- Halofuginone to treat fibrosis in chronic graft-versus-host disease and sclerodermaTransplantation and Cellular Therapy, 2003